| Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative Laura Vallejo‐Torres et al. | 2026 | 1 citations |
| Lost in Translation? A Scoping Review to Explore the Translation and Cultural Adaptation of Preference-Based Measures of Quality of Life Jenny Cleland et al. | 2026 | 1 citations |
| Estimation of ‘spectrum value’: A discrete choice experiment to investigate the willingness-to-pay for narrow-spectrum based on other antimicrobial characteristics Nadine T. Hillock et al. | 2026 | 0 citations |
| Partnerships in Public Health Economics: Reflective Lessons from UK Obesity Research Humera Sultan et al. | 2026 | 0 citations |
| Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them? Rachel J. Oidtman et al. | 2026 | 0 citations |
| Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening Max Lelie et al. | 2026 | 0 citations |
| It’s Time to Rethink ‘Real-World Evidence’: A Call for Terminological Clarity in Health Technology Assessment Hesam Ghiasvand & Haipeng Liu | 2026 | 0 citations |
| Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health Interventions Rositsa Koleva‐Kolarova et al. | 2026 | 0 citations |
| Preferences of Women for Maternal Health Services in Sidama Region, Ethiopia: Discrete Choice Experiment DG Belay et al. | 2026 | 0 citations |
| Economic Evaluation of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa Rochelle Woudberg & Edina Sinanovic | 2026 | 0 citations |
| The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics Lorenzo Martellone et al. | 2026 | 0 citations |
| Policy Levers for First-Contact Healthcare Provider Choice: A Discrete Choice Experiment in Shanghai’s Hierarchical Medical System Yi Gong | 2026 | 0 citations |
| Cost-Effectiveness and Public Health Impact of Newborn Screening for Spinal Muscular Atrophy in France Sebastien Eymere et al. | 2026 | 0 citations |
| The Increasing Value of Environmental Sustainability Assessments in Healthcare Policy and Technology Evaluation Lindsay Nicholson et al. | 2026 | 0 citations |
| Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and Eradication Megha Rao et al. | 2026 | 0 citations |
| Insights from Patient and Public Involvement (PPI) in Economic Evaluations of Severe Mental Illness: Comparing Recovering Quality of Life (ReQoL) and the EQ-5D-5L Gemma Shields et al. | 2026 | 0 citations |
| The Economic Value of Non-pharmaceutical Interventions for Influenza and COVID-19: A Systematic Review Hui Yee Yeo et al. | 2026 | 0 citations |
| A Systematic Review of Microsimulation Models in Cardiometabolic Disease: Model Calibration and Validation Danwei Yang et al. | 2026 | 0 citations |
| Agreement in Qualitative and Quantitative Assessments of Disease Severity: Evidence from Pharmaceutical Reimbursement in Sweden Martin Henriksson et al. | 2026 | 0 citations |
| Towards Environmentally Extended Health Economic Analysis Plans: A Case Study for the MEL-SELF Trial Jake T W Williams et al. | 2026 | 0 citations |